Kamagra Oral Jelly contains sildenafil citrate, the same active ingredient as Viagra, and is classified as a phosphodiesterase type 5 (PDE-5) inhibitor. It works by selectively inhibiting the PDE-5 enzyme, which is responsible for breaking down cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. When PDE-5 is inhibited, cGMP accumulates, resulting in relaxation of smooth muscle cells and improved blood flow to the penis during sexual stimulation.
Simply put, the drug helps the blood vessels in the penis widen when you’re sexually aroused, making it easier to get and maintain an erection. It will not cause an erection without sexual stimulation.
Metaphor: Imagine cGMP as the “green light” for an erection. PDE-5 is the “red light” that stops it. Kamagra Oral Jelly removes some of the red lights, but you still need the traffic (sexual stimulation) to get things moving.
According to recent studies (see PubMed reference), sildenafil’s mechanism has been well-established for over two decades, and its safety/effectiveness are confirmed in multiple randomized controlled trials. However, these studies almost exclusively use FDA-approved formulations—there is minimal or no clinical data for Kamagra Oral Jelly specifically, especially in U.S. populations.

